This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gerna, G Articles by Morini, F Search for Related Content PubMed PubMed Citation Articles by Gerna, G Articles by Morini, F

Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemia.

Institute of Infectious Diseases, Policlinico S. Matteo, University of Pavia, Italy.

ABSTRACT

The main parameters of immunostaining techniques, i.e., the type of fixative, immunocytochemical reaction, and quality of monoclonal antibodies (MAbs), for quantitation of human cytomegalovirus (HCMV) antigenemia in peripheral blood polymorphonuclear leukocytes (currently performed by the indirect immunofluorescence or immunoperoxidase reaction by using MAbs to HCMV pp65) were investigated in order to optimize procedural steps and reagents. Significantly better results (in terms of the number of positive cells) were obtained on multiple cytospin preparations from heart transplant recipients with HCMV viremia when we used (i) formalin instead of methanol-acetone fixation and (ii) the indirect immunofluorescence reaction instead of the immunoperoxidase reaction, the avidin-biotin complex method, or the alkaline phosphatase antialkaline phosphatase procedure. In addition, comparison of the staining capabilities of three MAbs to pp65, which were developed in the laboratory and which were reactive to different epitopes of the protein, with a commercially available MAb (Clonab CMV) for determination of HCMV antigenemia showed that, while individual MAbs did not provide better results, the pool of MAbs detected a significantly higher number of positive peripheral blood polymorphonuclear leukocytes than Clonab CMV did. In addition, the sensitivity of the pool in detecting patients with low levels of viremia (less than 5/2 x 10(5) cells inoculated) as antigenemia positive was 100%, whereas the sensitivity of Clonab CMV was 47%. No differences in the specificities between the two MAb preparations were observed.

This article has been cited by other articles:

• Gerna, G., Sarasini, A., Patrone, M., Percivalle, E., Fiorina, L., Campanini, G., Gallina, A., Baldanti, F., Revello, M. G. (2008). Human cytomegalovirus serum neutralizing antibodies block virus infection of endothelial/epithelial cells, but not fibroblasts, early during primary infection. J. Gen. Virol. 89: 853-865 [Abstract] [Full Text]  
• Lilleri, D., Fornara, C., Chiesa, A., Caldera, D., Alessandrino, E. P., Gerna, G. (2008). Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection. haematol 93: 248-256 [Abstract] [Full Text]  
• Lilleri, D., Gerna, G., Furione, M., Bernardo, M. E., Giorgiani, G., Telli, S., Baldanti, F., Locatelli, F. (2007). Use of a DNAemia cut-off for monitoring human cytomegalovirus infection reduces the number of preemptively treated children and young adults receiving hematopoietic stem-cell transplantation compared with qualitative pp65 antigenemia. Blood 110: 2757-2760 [Abstract] [Full Text]  
• Lilleri, D., Gerna, G., Fornara, C., Lozza, L., Maccario, R., Locatelli, F. (2006). Prospective simultaneous quantification of human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in young recipients of allogeneic hematopoietic stem cell transplants. Blood 108: 1406-1412 [Abstract] [Full Text]  
• Ueno, T., Eizuru, Y., Katano, H., Kurata, T., Sata, T., Irie, S., Ogawa-Goto, K. (2006). Novel Real-Time Monitoring System for Human Cytomegalovirus- Infected Cells In Vitro That Uses a Green Fluorescent Protein-PML-Expressing Cell Line.. Antimicrob. Agents Chemother. 50: 2806-2813 [Abstract] [Full Text]  
• Gerna, G., Baldanti, F., Percivalle, E., Zavattoni, M., Campanini, G., Revello, M. G. (2003). Early Identification of Human Cytomegalovirus Strains by the Shell Vial Assay Is Prevented by a Novel Amino Acid Substitution in UL123 IE1 Gene Product. J. Clin. Microbiol. 41: 4494-4495 [Full Text]  
• Baldanti, F., Gerna, G. (2003). Human cytomegalovirus resistance to antiviral drugs: diagnosis, monitoring and clinical impact. J Antimicrob Chemother 52: 324-330 [Abstract] [Full Text]  
• Hadaya, K., Wunderli, W., Deffernez, C., Martin, P.-Y., Mentha, G., Binet, I., Perrin, L., Kaiser, L. (2003). Monitoring of Cytomegalovirus Infection in Solid-Organ Transplant Recipients by an Ultrasensitive Plasma PCR Assay. J. Clin. Microbiol. 41: 3757-3764 [Abstract] [Full Text]  
• Gerna, G., Lilleri, D., Baldanti, F., Torsellini, M., Giorgiani, G., Zecca, M., De Stefano, P., Middeldorp, J., Locatelli, F., Revello, M. G. (2003). Human cytomegalovirus immediate-early mRNAemia versus pp65 antigenemia for guiding pre-emptive therapy in children and young adults undergoing hematopoietic stem cell transplantation: a prospective, randomized, open-label trial. Blood 101: 5053-5060 [Abstract] [Full Text]  
• Gerna, G., Percivalle, E., Sarasini, A., Baldanti, F., Campanini, G., Revello, M. G. (2003). Rescue of human cytomegalovirus strain AD169 tropism for both leukocytes and human endothelial cells. J. Gen. Virol. 84: 1431-1436 [Abstract] [Full Text]  
• Kaiser, L., Perrin, L., Chapuis, B., Hadaya, K., Kolarova, L., Deffernez, C., Huguet, S., Helg, C., Wunderli, W. (2002). Improved Monitoring of Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation by an Ultrasensitive Plasma DNA PCR Assay. J. Clin. Microbiol. 40: 4251-4255 [Abstract] [Full Text]  
• Revello, M. G., Gerna, G. (2002). Diagnosis and Management of Human Cytomegalovirus Infection in the Mother, Fetus, and Newborn Infant. Clin. Microbiol. Rev. 15: 680-715 [Abstract] [Full Text]  
• Gerna, G., Percivalle, E., Sarasini, A., Baldanti, F., Revello, M. G. (2002). The attenuated Towne strain of human cytomegalovirus may revert to both endothelial cell tropism and leuko- (neutrophil- and monocyte-) tropism in vitro. J. Gen. Virol. 83: 1993-2000 [Abstract] [Full Text]  
• Solano, C., Munoz, I., Gutierrez, A., Farga, A., Prosper, F., Garcia-Conde, J., Navarro, D., Gimeno, C. (2001). Qualitative Plasma PCR Assay (AMPLICOR CMV Test) versus pp65 Antigenemia Assay for Monitoring Cytomegalovirus Viremia and Guiding Preemptive Ganciclovir Therapy in Allogeneic Stem Cell Transplantation. J. Clin. Microbiol. 39: 3938-3941 [Abstract] [Full Text]  
• Grazia Revello, M., Baldanti, F., Percivalle, E., Sarasini, A., De-Giuli, L., Genini, E., Lilleri, D., Labò, N., Gerna, G. (2001). In vitro selection of human cytomegalovirus variants unable to transfer virus and virus products from infected cells to polymorphonuclear leukocytes and to grow in endothelial cells. J. Gen. Virol. 82: 1429-1438 [Abstract] [Full Text]  
• Ho, S. K. N., Li, F.-K., Lai, K.-N., Chan, T.-M. (2000). Comparison of the CMV Brite Turbo Assay and the Digene Hybrid Capture CMV DNA (Version 2.0) Assay for Quantitation of Cytomegalovirus in Renal Transplant Recipients. J. Clin. Microbiol. 38: 3743-3745 [Abstract] [Full Text]  
• Landry, M. L., Ferguson, D. (2000). Reduced Ability To Culture Cytomegalovirus from Peripheral Blood Leukocytes Isolated by Direct Erythrocyte Lysis. J. Clin. Microbiol. 38: 3906-3906 [Full Text]  
• Schäfer, P., Tenschert, W., Schröter, M., Gutensohn, K., Laufs, R. (2000). False-Positive Results of Plasma PCR for Cytomegalovirus DNA due to Delayed Sample Preparation. J. Clin. Microbiol. 38: 3249-3253 [Abstract] [Full Text]  
• Lipson, S. M., Della-Latta, P. (2000). Leukocyte Concentration in the Performance of the pp65 Antigenemia Assay. J. Clin. Microbiol. 38: 3137-3138 [Full Text]  
• Gerna, G., Percivalle, E., Baldanti, F., Sozzani, S., Lanzarini, P., Genini, E., Lilleri, D., Revello, M. G. (2000). Human Cytomegalovirus Replicates Abortively in Polymorphonuclear Leukocytes after Transfer from Infected Endothelial Cells via Transient Microfusion Events. J. Virol. 74: 5629-5638 [Abstract] [Full Text]  
• Gerna, G., Baldanti, F., Lilleri, D., Parea, M., Alessandrino, E., Pagani, A., Locatelli, F., Middeldorp, J., Revello, M. G. (2000). Human Cytomegalovirus Immediate-Early mRNA Detection by Nucleic Acid Sequence-Based Amplification as a New Parameter for Preemptive Therapy in Bone Marrow Transplant Recipients. J. Clin. Microbiol. 38: 1845-1853 [Abstract] [Full Text]  
• Alvarez-Barrientos, A., Arroyo, J., Canton, R., Nombela, C., Sanchez-Perez, M. (2000). Applications of Flow Cytometry to Clinical Microbiology. Clin. Microbiol. Rev. 13: 167-195 [Abstract] [Full Text]  
• St. George, K., Boyd, M. J., Lipson, S. M., Ferguson, D., Cartmell, G. F., Falk, L. H., Rinaldo, C. R., Landry, M. L. (2000). A Multisite Trial Comparing Two Cytomegalovirus (CMV) pp65 Antigenemia Test Kits, Biotest CMV Brite and Bartels/Argene CMV Antigenemia. J. Clin. Microbiol. 38: 1430-1433 [Abstract] [Full Text]  
• Sia, I. G., Patel, R. (2000). New Strategies for Prevention and Therapy of Cytomegalovirus Infection and Disease in Solid-Organ Transplant Recipients. Clin. Microbiol. Rev. 13: 83-121 [Abstract] [Full Text]  
• Landry, M. L., Ferguson, D. (2000). 2-Hour Cytomegalovirus pp65 Antigenemia Assay for Rapid Quantitation of Cytomegalovirus in Blood Samples. J. Clin. Microbiol. 38: 427-428 [Abstract] [Full Text]  
• Revello, M. G., Zavattoni, M., Furione, M., Baldanti, F., Gerna, G. (1999). Quantification of Human Cytomegalovirus DNA in Amniotic Fluid of Mothers of Congenitally Infected Fetuses. J. Clin. Microbiol. 37: 3350-3352 [Abstract] [Full Text]  
• Gerna, G., Baldanti, F., Middeldorp, J. M., Furione, M., Zavattoni, M., Lilleri, D., Revello, M. G. (1999). Clinical Significance of Expression of Human Cytomegalovirus pp67 Late Transcript in Heart, Lung, and Bone Marrow Transplant Recipients as Determined by Nucleic Acid Sequence-Based Amplification. J. Clin. Microbiol. 37: 902-911 [Abstract] [Full Text]  
• Gerna, G., Percivalle, E., Torsellini, M., Revello, M. G. (1998). Standardization of the Human Cytomegalovirus Antigenemia Assay by Means of In Vitro-Generated pp65-Positive Peripheral Blood Polymorphonuclear Leukocytes. J. Clin. Microbiol. 36: 3585-3589 [Abstract] [Full Text]  
• Bush, C. E., Sluchak-Carlsen, J. A. (1998). Evaluation of a Leukocyte Stabilization Reagent for Use in the Cytomegalovirus pp65 Antigenemia Assay. J. Clin. Microbiol. 36: 3410-3411 [Abstract] [Full Text]  
• Boeckh, M., Boivin, G. (1998). Quantitation of Cytomegalovirus: Methodologic Aspects and Clinical Applications. Clin. Microbiol. Rev. 11: 533-554 [Abstract] [Full Text]  
• Schäfer, P., Tenschert, W., Cremaschi, L., Gutensohn, K., Laufs, R. (1998). Utility of Major Leukocyte Subpopulations for Monitoring Secondary Cytomegalovirus Infections in Renal-Allograft Recipients by PCR. J. Clin. Microbiol. 36: 1008-1014 [Abstract] [Full Text]  
• Gerna, G., Zavattoni, M., Percivalle, E., Grossi, P., Torsellini, M., Revello, M. G. (1998). Rising Levels of Human Cytomegalovirus (HCMV) Antigenemia during Initial Antiviral Treatment of Solid-Organ Transplant Recipients with Primary HCMV Infection. J. Clin. Microbiol. 36: 1113-1116 [Abstract] [Full Text]  
• Ho, S. K. N., Lo, C.-Y., Cheng, I. K. P., Chan, T.-M. (1998). Rapid Cytomegalovirus pp65 Antigenemia Assay by Direct Erythrocyte Lysis and Immunofluorescence Staining. J. Clin. Microbiol. 36: 638-640 [Abstract] [Full Text]